Volume-based assessment by 18F-FDG PET/CT predicts survival in patients with stage III non-small-cell lung cancer

SH Hyun, HK Ahn, H Kim, MJ Ahn, K Park… - European journal of …, 2014 - Springer
Purpose We evaluated the prognostic impact of volume-based assessment by 18 F-FDG
PET/CT in patients with stage III non-small-cell lung cancer (NSCLC). Methods We reviewed …

Prognostic value of volumetric parameters measured by F-18 FDG PET/CT in surgically resected non-small-cell lung cancer

K Kim, SJ Kim, IJ Kim, YS Kim, K Pak… - Nuclear medicine …, 2012 - journals.lww.com
Objectives The aim of this study was to evaluate the usefulness of the tumor burden as
characterized by the metabolic tumor volume (MTV) and total lesion glycolysis (TLG) …

Prognostic value of volumetric parameters of 18F-FDG PET in non-small-cell lung cancer: a meta-analysis

HJ Im, K Pak, GJ Cheon, KW Kang, SJ Kim… - European journal of …, 2015 - Springer
Purpose We conducted a comprehensive systematic review of the literature on volumetric
parameters from 18 F-FDG PET and a meta-analysis of the prognostic value of metabolic …

Prognostic value of volumetric parameters on staging and posttreatment FDG PET/CT in patients with stage IV non–small cell lung cancer

JW Lee, SM Lee, M Yun, A Cho - Clinical nuclear medicine, 2016 - journals.lww.com
Purpose This study aimed to evaluate the prognostic value of metabolic tumor burden as
measured with metabolic tumor volume (MTV) and total lesion glycolysis (TLG), as well as …

Prognostic implications of volume-based measurements on FDG PET/CT in stage III non-small-cell lung cancer after induction chemotherapy

M Soussan, K Chouahnia, JA Maisonobe… - European journal of …, 2013 - Springer
Purpose We sought to determine whether metabolic volume-based measurements on FDG
PET/CT scans could provide additional information for predicting outcome in patients with …

Total metabolic tumor volume by 18F-FDG PET/CT for the prediction of outcome in patients with non-small cell lung cancer

S Pellegrino, R Fonti, E Mazziotti, L Piccin… - Annals of Nuclear …, 2019 - Springer
Objective Metabolic tumor volume (MTV) and total lesion glycolysis (TLG) are imaging
parameters derived from 18F-FDG PET/CT that have been proposed for risk stratification of …

Measurement of tumor volume by PET to evaluate prognosis in patients with advanced non-small cell lung cancer treated by non-surgical therapy

H Yan, R Wang, F Zhao, K Zhu, S Jiang… - Acta …, 2011 - journals.sagepub.com
Background Patients with advanced non-small cell lung cancer (NSCLC) seem to have
disparity in prognosis. Accurate prediction of prognosis could be useful in the future to …

Metabolic tumor volume measured by F-18 FDG PET/CT can further stratify the prognosis of patients with stage IV non-small cell lung cancer

SW Yoo, J Kim, A Chong, SY Kwon, JJ Min… - Nuclear medicine and …, 2012 - Springer
Purpose This study aimed to further stratify prognostic factors in patients with stage IV non-
small cell lung cancer (NSCLC) by measuring their metabolic tumor volume (MTV) using F …

Volume-based parameters of 18F-fluorodeoxyglucose positron emission tomography/computed tomography improve outcome prediction in early-stage non–small cell …

SH Hyun, JY Choi, K Kim, J Kim, YM Shim… - Annals of …, 2013 - journals.lww.com
Objective: To evaluate the prognostic significance and predictive performance of volume-
based parameters of 18 F-fluorodeoxyglucose positron emission tomography/computed …

Optimal FDG PET/CT volumetric parameters for risk stratification in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668/RTOG 0235 …

A Salavati, F Duan, BS Snyder, B Wei… - European journal of …, 2017 - Springer
Purpose In recent years, multiple studies have demonstrated the value of volumetric FDG-
PET/CT parameters as independent prognostic factors in patients with non-small cell lung …